Health

GenScript and Duke-NUS announce notice of allowance for “Surrogate Virus Neutralization Technology” – News-Medical.Net

GenScript Biotech Corporation (“GenScript”, Stock Code: 1548.HK), a world-leading life sciences research and application service…

Published

4 years ago

June 23, 2021

Noosa Online News Publisher

GenScript Biotech Corporation (“GenScript”, Stock Code: 1548.HK), a world-leading life sciences research and application service and product provider, and Duke-NUS Medical School, a premier, research intensive medical school, announced today that the U.S….

Click here to view the original article.

Related Topics:Australia News-Medical.Net

Up Next

New project aims to identify quantitative biological features common across diseases – News-Medical.Net

Don't Miss

mRNA COVID-19 vaccines may increase patients’ concerns about side effects – News-Medical.Net

General22 hours ago

German backpacker Carolina Wilga found alive in WA’s outback

General12 hours ago

Thailand punches above its weight in film creativity and cross-border appeal. Here’s why

General5 hours ago

AFL Round 18 live updates: Bulldogs vs Crows, Giants vs Cats, Tigers vs Bombers, Dockers vs Hawks — blog, scores and stats

General23 hours ago

Victims of crypto ATM scams lose $2.5 million as police warn older Tasmanians are targets

Noosa Online News

GenScript and Duke-NUS announce notice of allowance for “Surrogate Virus Neutralization Technology” – News-Medical.Net

Trending